
Clinical data modernization is one of those phrases that shows up everywhere and means something different to almost everyone. In some contexts, it refers to cloud infrastructure. In others, it points to advanced analytics or artificial intelligence. For many clinical teams, it simply signals that current ways of working are starting to strain under growing…

As clinical trial operations approach 2026, the conversation around technology is shifting. Tools that were once framed as innovative or experimental are becoming standard. Artificial intelligence, automation, and unified platforms are increasingly seen as baseline needs for running modern trials. This change is being driven by practical pressures rather than novelty. Studies are more distributed,…

With the holidays upon us, we’ve been reflecting on our favorite takeaways from the past year – with our clients and partners, the TrialKit platform, and our team at CDS. Scroll through this post to see what topped our list of highlights from 2022.

CDS has many innovative updates in store for TrialKit in 2021. Check out this blog post for a quick glance at what’s to come to the platform in the upcoming year.

As we bid farewell to 2018 and begin rounding the corner to 2019, we find ourselves reflecting on all we’ve achieved this year. Our team enjoyed supporting research professionals worldwide as they built studies, deployed to sites around the globe, and continued to efficiently collect data using the platform’s latest technologies.

As we enjoy the last week of 2017 at Crucial Data Solutions, we find ourselves reflecting on progress and growth. One month after the next, we were busy with product updates, releases, and customer relationships.

2017 is slated to be an exciting year for us here at Crucial Data Solutions. Read on to learn more about upcoming system enhancements and plans for the TrialKit platform.

We often get this question: what’s next in technology for Crucial Data Solutions? As technology constantly evolves, the answer to this question changes frequently. So, what is on the docket for us in the upcoming months?